# Bone Biologics Corporation (BBLG)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/BBLG/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 0 | $ -3.18M | $ -2.76M | $ 0 | $ 5.38M |
| 2024 | $ 0 | $ -4.32M | $ -4.34M | $ 0 | $ 3.48M |
| 2023 | $ 0 | $ -9.68M | $ -10.33M | $ 0 | $ 2.91M |
| 2022 | $ 0 | $ -1.66M | $ -3.98M | $ 0 | $ 5.95M |
| 2021 | $ 0 | $ -1.91M | $ -1.46M | $ 0 | $ 6.58M |
| 2020 | $ 0 | $ -2.32M | $ -543.9K | $ 11.72M | $ -13.69M |
| 2019 | $ 0 | $ -4.42M | $ -4.20M | $ 11.32M | $ -11.87M |
| 2018 | $ 0 | $ -5.85M | $ -5.42M | $ 9.00M | $ -8.60M |
| 2017 | $ 0 | $ -9.30M | $ -4.49M | $ 8.23M | $ -8.40M |
| 2016 | $ 0 | $ -28.93M | $ -10.08M | $ 7.48M | $ -8.36M |
| 2015 | $ 0 | $ -19.48M | $ -5.00M | $ 5.62M | $ -5.68M |
| 2014 | $ 0 | $ -6.76M | $ -4.11M | $ 7.30M | $ -3.70M |
| 2013 | $ 0 | $ -1.12M | $ -544.9K | $ 0 | $ -38.8K |
| 2012 | N/A | N/A | $ -7.0K | $ 0 | $ 0 |
| 2011 | N/A | N/A | $ -5.3K | N/A | N/A |
| 2010 | N/A | N/A | $ -8.6K | N/A | N/A |
| 2009 | $ 0 | $ 0 | $ -7.4K | $ 0 | $ 0 |
| 2008 | N/A | N/A | $ -17.4K | $ 0 | $ 0 |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.08 |
| Current Ratio | 13.85 |

## Other views

- [Metrics](https://sponda.capital/en/BBLG.md)
- [Charts](https://sponda.capital/en/BBLG/charts.md)
- [Compare](https://sponda.capital/en/BBLG/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.